Trial record 1 of 2 for:    TKM-080301
Previous Study | Return to List | Next Study

A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

This study is currently recruiting participants.
Verified February 2014 by Tekmira Pharmaceuticals Corporation
Sponsor:
Information provided by (Responsible Party):
Tekmira Pharmaceuticals Corporation
ClinicalTrials.gov Identifier:
NCT01262235
First received: December 15, 2010
Last updated: February 27, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)